Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer

Scientific publication - Journal Article uoadl:2951041 28 Read counter

Description
Contents

Unit:

Faculty of Medicine

Title:

Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer

Languages of Item:

English

Abstract:

Empty abstract

Publication year:

2012

Authors:

Stefanadis, Christodoulos
Synetos, Andreas
Tousoulis, Dimitris
Tsiamis, Eleftherios
Michelongona, Archontoula
Zagouri, Flora
Bamias, Aristotle
Dimopoulos, Meletios Athanasios
Kyvelou, Stella
Kapelakis, Ioannis
others

Journal:

International Journal of Cardiology

Publisher:

Elsevier

Volume:

154

Number:

Pages:

341--344

Main subject category:

Health Sciences

Persistent URL:

https://pergamos.lib.uoa.gr/uoa/dl/object/2951041

Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer

The digital material of the item is not available.